Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Perrigo Company Public Limited Company (PRGO)

-NYSE
150.45 Down 3.44(2.24%) 4:03PM EDT
|After Hours : 150.40 Down 0.05 (0.03%) 6:40PM EDT
ProfileGet Profile for:
Perrigo Company Public Limited Company
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland - Map
Phone: 353 1 604 0031
Website: http://www.perrigo.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Related Products
Full Time Employees:9,900

Business Summary 

Perrigo Company Public Limited Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API) primarily in the United States, Israel, the United Kingdom, Mexico, and Australia. Its Consumer Healthcare business offers various OTC and nutrition products, including analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as well as vitamins, dietary supplements, and nutritional drinks. The company’s Nutritionals business develops, manufactures, markets, and distributes infant formula, pediatric nutritionals and vitamins, minerals, and supplements primarily under the Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex brands. Its Rx Pharmaceuticals business develops, manufactures, and markets a portfolio of generic prescription drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, and oral liquids and oral solid dosage forms. The company’s Active Pharmaceutical Ingredients (API) business develops, manufactures, and markets differentiated APIs and finished dosage forms for the branded and generic pharmaceutical industries. In addition, Perrigo Company Public Limited Company is developing TYSABRI for the treatment of multiple sclerosis and crohn’s disease; and ELND005 for the treatment of Alzheimer’s disease and bipolar disorder. Its Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses; and imports other pharmaceutical and medical diagnostic products. The company sells its products to drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. Perrigo Company Public Limited Company was founded in 1887 and is headquartered in Dublin, Ireland.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Perrigo Company Public Limited Company

Corporate Governance 
Perrigo Company Public Limited Company’s ISS Governance QuickScore as of Jul 1, 2014 is 5. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 2; Compensation: 6.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Joseph C. Papa , 58
Chairman, Chief Exec. Officer and Pres
2.19M9.59M
Ms. Judy L. Brown , 46
Chief Financial Officer, Principal Accounting Officer and Exec. VP
905.00K1.38M
Mr. Todd W. Kingma , 54
Exec. VP, Gen. Counsel and Sec.
763.00K1.24M
Mr. John T. Hendrickson , 51
Exec. VP of Global Operations and Supply Chain
772.00K601.00K
Mr. Sharon Kochan , 46
Exec. VP and Gen. Mang. of International
740.00K620.00K
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders